Anti–PD-1 inhibitor–related pneumonitis in non–small cell lung cancer

The recent approval of two PD-1 inhibitors for the treatment of non–small cell lung cancer (NSCLC) has rapidly led to the widespread use of these agents in oncology practices. Pneumonitis has been recognized as a potentially life-threatening adverse event among NSCLC patients treated with PD-1 inhib...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Immunol Res
Main Authors: Nishino, Mizuki, Chambers, Emily S., Chong, Curtis R., Ramaiya, Nikhil H., Gray, Stacy W., Marcoux, J. Paul, Hatabu, Hiroto, Jänne, Pasi A., Hodi, F. Stephen, Awad, Mark M.
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4818710/
https://ncbi.nlm.nih.gov/pubmed/26865455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-15-0267
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker